RE:Aphria is a real diamondThis is precisely why I am holding on despite the grind.
I appreciate that Aphria was lagging last Fall when we all thought it should have been doing better relative to its peers. Sadly we now know why (thank you Vic/Andy).
I cannot help but think the lingering distrust is what keeps this down. Indeed, rec sales are not helping the sector, but sheesh, how long does this linger? Your synopsis below has me bewildered (I came to similar numbers).
A billion dollar goal is a pretty bold statement, but Mr. Irwin seems serious, and he is bringing in serious board members.
Once again I hope this is another one of those days we will laugh about some day...just not today.
N00bInvesT0R wrote:
Aphria Net revenues after excise taxes ( 73,582 M) : https://aphria.ca/wp-content/uploads/2019/04/aphria-Q3-2019-inerim-financial-statements.pdf
Weed Net revenues after excise taxes (83,048 M) : https://www.canopygrowth.com/wp-content/uploads/2019/02/Canopy-Growth-Corporation_Q3_2019-Financial-Statements_FINAL.pdf
Aurora Net revenues after excise taxes (54,178 M) : https://aphria.ca/wp-content/uploads/2019/04/aphria-Q3-2019-inerim-financial-statements.pdf
Let me spare you the maths, Aphria has a market cap 4 times smaller than Aurora on top of having almost 5 times less outstanding shares (dilution horrible) yet they managed to outperform Aurora by 36%.
Aphria and Weed no dilution problems but Aphria almost 6.5 times small than Weed yet Weed only outperformed Aphria by 11%.
Doesn't take a genius to understand whats next for Aphria in terms of valuation if the market is willing to accept Weed and Aurora valuation after getting outshined by Aphria
(Yes I know its CC pharma and the Argentine company that generated the most, I can care less, at least Aphria acquisition brings value to shareholders unlike other Mj companies acquisitions)
Good luck